je.st
news
Tag: fda
The FDA Must Define 'Natural' Soon
2013-05-24 09:00:55| Food Processing
50 different state laws on labeling natural and genetically engineered foods would harm us all.
FDA panel backs experimental Merck insomnia drug
2013-05-23 19:42:13| Biotech - Topix.net
A federal panel of medical experts said that an experimental insomnia drug from Merck & Co.
Tags: panel
drug
experimental
backs
Merck Statement on FDA Advisory Committee Meeting for Suvorexant
2013-05-23 00:28:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration (FDA) about suvorexant, Mercks investigational medicine to treat insomnia. Language: English Contact HTML: MerckMedia:Pam Eisele, 908-423-5042orTracy Ogden, 267-305-2301orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: statement
meeting
committee
advisory
Varian Medical Systems Receives FDA 510(k) Clearance of Its Nexus DRF Digital X-Ray Imaging ...
2013-05-22 06:00:00| Industrial Newsroom - All News for Today
SALT LAKE CITY -- Varian Medical Systems (NYSE:VAR) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Varian's diagnostic X-ray image processing workstation that combines radiography/fluoroscopy (RF) and digital radiography (DR) capabilities on one platform. Varian's Nexus DRF Digital X-Ray Imaging System™ has the ability to interface with a variety of image receptors, including CCD cameras and commercially available flat-panel image ...This story is related to the following:Vision SystemsSearch for suppliers of: Medical Imaging Systems
Tags: digital
systems
medical
clearance
FDA has safety concerns with Merck insomnia drug
2013-05-20 21:15:54| Biotech - Topix.net
The Food and Drug Administration on Monday released its review of the company's sleep aid, suvorexant, ahead of a public meeting on Wednesday.
Tags: safety
drug
concerns
fda
Sites : [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] next »